Abstract:Mesenchymal stem cells (MSCs) have been widely documented for their potential role in the treatment of various clinical disorders, including acute lung injury (ALI). ALI represents a clinical syndrome associated with histopathological diffuse alveolar damage. Recent evidence has demonstrated that exosomes derived from MSCs may serve as a reservoir of anti-apoptotic microRNAs (miRs) conferring protection from certain diseases. Hence, the current study was performed with the aim of investigating whether MSCs-exosomal miR-30b-3p could confer protection against ALI. A bioinformatic analysis and a dual luciferase assay were initially performed to verify that SAA3 was highly-expressed in ALI which was confirmed to be a target gene of miR-30b-3p. Next, the lipopolysaccharide (LPS)-treated type II alveolar epithelial cells (AECs) (MLE-12) were transfected with mimics or inhibitors of miR-30b-3p, or sh-SAA3. It was revealed that LPS induced AEC apoptosis, which could be inhibited by overexpressing miR-30b-3p by down-regulating the expression of SAA3. After co-culture of PKH26-labeled exosomes with MLE-12 cells, we found that the number of PKH26-labeled exosomes endocytosed by MLE-12 cells gradually increased. Furthermore, the LPS-treated MLE-12 cells co-cultured with MSC-exosomes overexpressing miR-30b-3p exhibited increased miR-30b-3p, decreased SAA3 level, as well as increased cell proliferation, accompanied by diminished cell apoptosis in LPS-treated MLE-12 cells. Finally, the protective effect of MSCs-exosomal miR-30b-3p on the AECs in vivo was investigated in an ALI mouse model with tail vein injection of MSC-exosomes with elevated miR-30b-3p, showing that overexpression of miR-30b-3p in MSC-exosomes conferred protective effects against ALI. Taken together, these findings highlighted the potential of MSC-exosomes overexpressing miR-30b-3p in preventing ALI. The exosomes derived from MSCs hold potential as future therapeutic strategies in the treatment of ALI.

Stem cell derived exosomes-based therapy for acute lung injury and acute respiratory distress syndrome: A novel therapeutic strategy

Advances in the use of exosomes for the treatment of ALI/ARDS

[Advances in the Research of Effects of Exosomes on Acute Lung Injury].

Paracrine Factors from Mesenchymal Stem Cells: a Proposed Therapeutic Tool for Acute Lung Injury and Acute Respiratory Distress Syndrome.

Exosomes of different cellular origins: prospects and challenges in the treatment of acute lung injury after burns

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome

Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease

Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges.

Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases

Treatment of Acute Respiratory Distress Syndrome with Allogeneic Adipose-Derived Mesenchymal Stem Cells: a Randomized, Placebo-Controlled Pilot Study.

Paracrine Effect of Stem Cells on Treatment of Acute Lung Injury/acute Respiratory Distress Syndrome

Mesenchymal Stem Cells-Derived Exosomes Alleviate Acute Lung Injury By Inhibiting Alveolar Macrophage Pyroptosis

Potential Therapeutic Application of Adult Stem Cells in Acute Respiratory Distress Syndrome.

Mesenchymal stem cell exosomes reverse acute lung injury through Nrf-2/ARE and NF- κ B signaling pathways

Recent progress in mesenchymal stem cell-based therapy for acute lung injury

Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.

Research Progress on Exosome-Mediated Immune Regulation of Acute Lung Injury

Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure

Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury

Exosomes Derived from Microrna-30B-3p-overexpressing Mesenchymal Stem Cells Protect Against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting SAA3.

Umbilical cord MSC‐derived exosomes improve alveolar macrophage function and reduce LPS‐induced acute lung injury